Integrated Whole-Genome Analysis of Hematologic Disorders
Completed
- Conditions
- Hematologic Diseases
- Registration Number
- NCT01108159
- Lead Sponsor
- Stanford University
- Brief Summary
We will use new technologies to look at the DNA, RNA, proteins, and metabolites in the disease-containing blood, bone marrow, or tissue and normal cells from the skin. Our goal is to analyze all of the genes in the diseased and normal skin sample. By comparing the results of the diseased sample and normal skin cells and the results of the two types of genetic information (DNA and RNA), we should be able to identify genetic changes that are important for the initiation, progression, or treatment response of that particular disorder.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
- 18 years of age or older
- Patient meets the clinical and/or pathologic criteria for the hematologic disorder being examined.
- Patient is willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.
Read More
Exclusion Criteria
- Less than 18 years of age
- Patient is not willing to provide a skin biopsy and five 10 mL tubes of peripheral blood.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to identify mutations, changes in DNA copy number, structural rearrangements, or altered coding and non-coding RNA expression sample collection at time of routine visit
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Stanford, California, United States